2023
DOI: 10.1158/0008-5472.22426117
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Supplementary Data from Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment

Abstract: <p>Supplementary Figures S1-S9 and tables S1-S6</p>

Help me understand this report
View published versions

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles